^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Non-Hodgkin’s Lymphoma
    Regimen:SMILE
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    01/05/2023
    Excerpt:
    Extranodal NK/T-Cell Lymphomas....INDUCTION THERAPY...Preferred regimens...Modified SMILE (steroid [dexamethasone], methotrexate, ifosfamide, pegaspargase, and etoposide) x 4–6 cycles for advanced stage.